FITB vs VVOS · P/E 17, rev $3.37B vs rev $10.3M
Fifth Third Bancorp (FITB) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Latest reported VVOS revenue for 2026-06-30 was $10.3M. Net income was -$13.2M. VVOS currently screens at market cap $7.1M.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the FITB and VVOS stock pages for the full models.
Not investment advice.